Duloxetine
NDC Package 42291-252-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Duloxetine is a . Marketed by Avkare, Inc., this product is identified by NDC 42291-252 and is authorized under FDA application ANDA090776.

Identification & Billing

NDC Package Code
42291-252-30
Package Description
30 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Product Code
42291-252
11-Digit Billing Format
42291025230
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Duloxetine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Avkare, Inc.
FDA Application #
ANDA090776
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-08-2014
End Marketing Date
08-03-2016
Listing Expiration
08-03-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42291-252). Click a package code to view its specific billing and regulatory data.

42291-252-50
500 CAPSULE, DELAYED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42291-252-30 identifies a specific commercial package of 30 capsule, delayed release in 1 bottle of Duloxetine, labeled by Avkare, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avkare, Inc. on July 08, 2014. The current certification is valid through August 03, 2016.

How is this Avkare, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42291025230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42291-252-30
11-Digit CMS (5-4-2)
42291-0252-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.